Human Immunodeficiency Virus 1 (HIV-1) PhenoSense Integrase-994

Test info

  
Human Immunodeficiency Virus 1 (HIV-1) PhenoSense Integrase
  
994
  
LAB994
  
MSO
  
INSTI
Integrase strand inhibitor
Monogram Integrase Inhibitor Resistance
PhenoSense integrase
Raltegravir
  

The PhenoSense Integrase® assay is a phenotypic resistance test used to determine the susceptibility of a patient's HIV to integrase inhibitors. Integrase inhibitors block HIV replication by preventing the virus from integrating into the host cell's DNA. Raltegravir (Isentress®) is the first approved drug in this class of HIV antiretroviral drugs.

Specimen

  
EDTA plasma
  
  
3.0 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

  
  1. Spin
  2. Transfer serum to aTransfer vial/tube for small volume specimens (Sarstedt), labelled as EDTA plasma
  3. Freeze immediately

Do not send specimens until they are completely frozen, as nucleic acid degradation occurs rapidly at ambient and higher temperatures.

Specimen integrity is compromised with freeze/thaw cycles.

 

  
  • Current viral load (≥ 500 copies/mL)
  

Frozen (strict)

Performance

  
Monogram Biosciences (S3200) via LabCorp (550230): R-NX
  
Varies
  
23 days
  

Polymerase chain reaction (PCR) amplification and viral culture

Clinical and Interpretive info

  

See report

Billing

  
87903

Tracking

  
06/05/2013
  
04/14/2022
  
04/12/2022